These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 38652677)
1. Classifying Glioma via Liquid Biopsy: Progress toward an Unmet Clinical Need. Abdullah KG Clin Cancer Res; 2024 Jul; 30(14):2860-2861. PubMed ID: 38652677 [TBL] [Abstract][Full Text] [Related]
2. Detection of tumor-derived cell-free DNA in cerebrospinal fluid using a clinically validated targeted sequencing panel for pediatric brain tumors. Ronsley R; Karvonen KA; Cole B; Paulson V; Stevens J; Crotty EE; Hauptman J; Lee A; Stasi SM; Lockwood CM; Leary SES J Neurooncol; 2024 Jun; 168(2):215-224. PubMed ID: 38755519 [TBL] [Abstract][Full Text] [Related]
3. Cell-free circulating tumor DNA in patients with high-grade glioma as diagnostic biomarker - A guide to future directive. Ahmed KI; Govardhan HB; Roy M; Naveen T; Siddanna P; Sridhar P; Suma MN; Nelson N Indian J Cancer; 2019; 56(1):65-69. PubMed ID: 30950448 [TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal Fluid cfDNA Sequencing for Classification of Central Nervous System Glioma. Iser F; Hinz F; Hoffmann DC; Grassl N; Güngoör C; Meyer J; Dörner L; Hofmann L; Kelbch V; Göbel K; Mahmutoglu MA; Vollmuth P; Patel A; Nguyen D; Kaulen LD; Mildenberger I; Sahm K; Maaß K; Pajtler KW; Shankar GM; Weiler M; Wildemann B; Winkler F; von Deimling A; Platten M; Wick W; Sahm F; Kessler T Clin Cancer Res; 2024 Jul; 30(14):2974-2985. PubMed ID: 38295147 [TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid tumor DNA for liquid biopsy in glioma patients' management: Close to the clinic? Simonelli M; Dipasquale A; Orzan F; Lorenzi E; Persico P; Navarria P; Pessina F; Nibali MC; Bello L; Santoro A; Boccaccio C Crit Rev Oncol Hematol; 2020 Feb; 146():102879. PubMed ID: 32005411 [TBL] [Abstract][Full Text] [Related]
6. Liquid biopsy for pediatric diffuse midline glioma: a review of circulating tumor DNA and cerebrospinal fluid tumor DNA. Azad TD; Jin MC; Bernhardt LJ; Bettegowda C Neurosurg Focus; 2020 Jan; 48(1):E9. PubMed ID: 31896079 [TBL] [Abstract][Full Text] [Related]
7. Liquid biopsy detection of genomic alterations in pediatric brain tumors from cell-free DNA in peripheral blood, CSF, and urine. Pagès M; Rotem D; Gydush G; Reed S; Rhoades J; Ha G; Lo C; Fleharty M; Duran M; Jones R; Becker S; Haller M; Sinai CE; Goumnerova L; Golub TR; Love JC; Ligon KL; Wright KD; Adalsteinsson VA; Beroukhim R; Bandopadhayay P Neuro Oncol; 2022 Aug; 24(8):1352-1363. PubMed ID: 34984433 [TBL] [Abstract][Full Text] [Related]
8. Diagnosis of pediatric central nervous system tumors using methylation profiling of cfDNA from cerebrospinal fluid. Cornelli L; Van Paemel R; Ferro Dos Santos MR; Roelandt S; Willems L; Vandersteene J; Baert E; Mus LM; Van Roy N; De Wilde B; De Preter K Clin Epigenetics; 2024 Jul; 16(1):87. PubMed ID: 38970137 [TBL] [Abstract][Full Text] [Related]
9. [The Present and Future of Less-invasive Liquid Biopsy for the Diagnosis of Gliomas and Brain Tumors]. Natsumeda M; On J; Watanabe J; Tsukamoto Y; Okada M; Fujii Y; Adachi J; Nishikawa R No Shinkei Geka; 2021 May; 49(3):527-534. PubMed ID: 34092558 [TBL] [Abstract][Full Text] [Related]
10. Integrating a Large Next-Generation Sequencing Panel into the Clinical Diagnosis of Gliomas Provides a Comprehensive Platform for Classification from FFPE Tissue or Smear Preparations. Parilla M; Kadri S; Patil SA; Fitzpatrick C; Ritterhouse L; Segal J; Collins J; Pytel P J Neuropathol Exp Neurol; 2019 Mar; 78(3):257-267. PubMed ID: 30698790 [TBL] [Abstract][Full Text] [Related]
11. Liquid biopsy in H3K27M diffuse midline glioma. Patel J; Aittaleb R; Doherty R; Gera A; Lau B; Messinger D; Wadden J; Franson A; Saratsis A; Koschmann C Neuro Oncol; 2024 May; 26(Supplement_2):S101-S109. PubMed ID: 38096156 [TBL] [Abstract][Full Text] [Related]
12. Standardization of the liquid biopsy for pediatric diffuse midline glioma using ddPCR. Li D; Bonner ER; Wierzbicki K; Panditharatna E; Huang T; Lulla R; Mueller S; Koschmann C; Nazarian J; Saratsis AM Sci Rep; 2021 Mar; 11(1):5098. PubMed ID: 33658570 [TBL] [Abstract][Full Text] [Related]
13. Molecular diagnosis of diffuse glioma using a chip-based digital PCR system to analyze IDH, TERT, and H3 mutations in the cerebrospinal fluid. Fujioka Y; Hata N; Akagi Y; Kuga D; Hatae R; Sangatsuda Y; Michiwaki Y; Amemiya T; Takigawa K; Funakoshi Y; Sako A; Iwaki T; Iihara K; Mizoguchi M J Neurooncol; 2021 Mar; 152(1):47-54. PubMed ID: 33417137 [TBL] [Abstract][Full Text] [Related]
14. Application of liquid biopsy in lung cancer management. Satapathy S; Thirunavukkarasu B; Jain D Indian J Pathol Microbiol; 2024 Jul; 67(3):492-501. PubMed ID: 39011609 [TBL] [Abstract][Full Text] [Related]
15. Role of Machine Learning in Liquid Biopsy of Brain Tumours. Javed Z; Bakhshi SK; Khan SA; Shamim MS J Pak Med Assoc; 2024 Jun; 74(6):1194-1196. PubMed ID: 38949002 [TBL] [Abstract][Full Text] [Related]
16. New perspectives in liquid biopsy for glioma patients. Pasqualetti F; Rizzo M; Franceschi S; Lessi F; Paiar F; Buffa FM Curr Opin Oncol; 2022 Nov; 34(6):705-712. PubMed ID: 36093876 [TBL] [Abstract][Full Text] [Related]
17. Molecular tumor analysis and liquid biopsy: a feasibility investigation analyzing circulating tumor DNA in patients with central nervous system lymphomas. Hickmann AK; Frick M; Hadaschik D; Battke F; Bittl M; Ganslandt O; Biskup S; Döcker D BMC Cancer; 2019 Mar; 19(1):192. PubMed ID: 30823914 [TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid cell-free tumour DNA as a liquid biopsy for primary brain tumours and central nervous system metastases. Seoane J; De Mattos-Arruda L; Le Rhun E; Bardelli A; Weller M Ann Oncol; 2019 Feb; 30(2):211-218. PubMed ID: 30576421 [TBL] [Abstract][Full Text] [Related]
19. Cell-Free Tumor DNA (cf-tDNA) Liquid Biopsy: Current Methods and Use in Brain Tumor Immunotherapy. Wadden J; Ravi K; John V; Babila CM; Koschmann C Front Immunol; 2022; 13():882452. PubMed ID: 35464472 [TBL] [Abstract][Full Text] [Related]
20. Detection of mutation profiles and tumor mutation burden of cerebrospinal fluid circulating DNA by a cancer genomic panel sequencing in glioma patients. Guo W; Jin L; Liang J; Lin G; Zheng J; Zhou D; Zhan S; Sun H; Jiang X Clin Chim Acta; 2022 Sep; 534():81-92. PubMed ID: 35810802 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]